CTX-009

CTX-009 · Compass Therapeutics

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CTX-009, covering 2025-04-20 to 2026-07-28. Get the full timeline:

Most recent: Clinical Trial Results: A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer [Phase 2]